Genomic profiling informs diagnoses and treatment in vascular anomaliesDong Li, Håkon Håkonarson, Jill Dayneka et al.|Nature Medicine|2023Cited by 63
Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSarah E. Sheppard, Håkon Håkonarson, Michael March et al.|JCI Insight|2023Cited by 37
Genetics etiologies and genotype phenotype correlations in a cohort of individuals with central conducting lymphatic anomalyMandi Liu, Sarah E. Sheppard, Christopher L. Smith et al.|European Journal of Human Genetics|2022Cited by 31
Pathogenic variants in<i>PIK3CA</i>are associated with clinical phenotypes of kaposiform lymphangiomatosis, generalized lymphatic anomaly, and central conducting lymphatic anomalyJeremy Grenier, Abhay Srinivasan, Alexandra J. Borst et al.|Pediatric Blood & Cancer|2023Cited by 19
Expanded phenotypic spectrum of <scp> <i>JAG1</i> </scp> ‐associated diseases: Central conducting lymphatic anomaly with a pathogenic variant in <scp> <i>JAG1</i> </scp>Dong Li, Håkon Håkonarson, Sarah E. Sheppard et al.|Clinical Genetics|2021Cited by 11